Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Lymphoproliferative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00479167
What this trial is testing

A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Follicular Lymphoma
Rush University Medical Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT04440267
What this trial is testing

Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage

Who this might be right for
Acute Leukemia of Ambiguous Lineage
Institute of Hematology & Blood Diseases Hospital, China 50
Testing effectiveness (Phase 2)Study completedNCT01030900
What this trial is testing

Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas

Who this might be right for
Hodgkin LymphomaDiffuse Large B-Cell Lymphoma
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Looking for participantsNCT05091372
What this trial is testing

Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous Hematopoietic Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Myeloma Multiple
M.D. Anderson Cancer Center 94
Not applicableStudy completedNCT02389101
What this trial is testing

Molecular and Whole-body MR Imaging in Lymphomas

Who this might be right for
LymphomaHodgkin DiseaseLymphoma, Non-Hodgkin
Turku University Hospital 21
Not applicableStudy completedNCT05541328
What this trial is testing

Comparison of Clinical Outcomes Among Patients Treated With Tisagenlecleucel

Who this might be right for
Diffuse Large B-cell Lymphoma
Novartis Pharmaceuticals 169
Large-scale testing (Phase 3)Study completedNCT00004165
What this trial is testing

Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Northwestern University
Testing effectiveness (Phase 2)Ended earlyNCT03705507
What this trial is testing

International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, AdultAcute Lymphoblastic Leukemia, Pediatric+2 more
University of Birmingham 12
Testing effectiveness (Phase 2)UnknownNCT04021992
What this trial is testing

GVD±R Regimen for ASCT-eligible Patients With Refractory/Relapsed DLBCL

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Sun Yat-sen University 48
Testing effectiveness (Phase 2)Study completedNCT01538472
What this trial is testing

Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00514475
What this trial is testing

Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Oslo University Hospital 160
Testing effectiveness (Phase 2)Study completedNCT00562328
What this trial is testing

Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Mayo Clinic 33
Large-scale testing (Phase 3)Study completedNCT03595800
What this trial is testing

Extension of a Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor to Younger Patients Eligible for Reduced-intensity Conditioning Regimen

Who this might be right for
Acute LeukemiaNon Hodgkin LymphomaMultiple Myeloma
Institut Paoli-Calmettes 9
Post-approval studies (Phase 4)Ended earlyNCT03173092
What this trial is testing

Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Takeda 141
Not applicableUnknownNCT04735211
What this trial is testing

Chronic Postsurgical Pediatric Pain. Evaluation Risk Factors to Develop Chronic Postsurgical Pain in Children and Adolescents Undergoing Surgery in a First Level Hospital

Who this might be right for
Chronic Postoperative PainPediatric ALL
Guillermo Ceniza Bordallo 260
Testing effectiveness (Phase 2)Study completedNCT00317811
What this trial is testing

Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Oncotherapeutics 35
Not applicableUnknownNCT04496011
What this trial is testing

Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation

Who this might be right for
FatigueLeukemiaLymphoma+2 more
Federal University of Health Science of Porto Alegre 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04115631
What this trial is testing

A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Liver LymphomaMantle Cell Lymphoma
ECOG-ACRIN Cancer Research Group 360
Not applicableStudy completedNCT01831739
What this trial is testing

Genomic Research in Sarcoidosis

Who this might be right for
Sarcoidosis
University of Pittsburgh 368
Not applicableLooking for participantsNCT06771830
What this trial is testing

Evaluation of Pediatric eCART Implementation

Who this might be right for
Pediatric ALLSepsis
University of Wisconsin, Madison 30,000
Next Page